Azacitidine: In Myelodysplastic Syndromes

Author： Siddiqui M. Asif A.   Scott Lesley J.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.13, 2005-01, pp. : 1781-1789

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Azacitidine prolongs survival in myelodysplastic syndromes

By  

Inpharma, Vol. 1, Iss. 1621, 2008-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

The role of azacitidine in the treatment of myelodysplastic syndromes

By Abdulhaq Haifaa   Rossetti James M  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 12, 2007-12 ,pp. : 1967-1975

Informa Healthcare

Access to resources Recommend Favorite

Azacitidine in Myelodysplastic Syndromes: A Viewpoint by Valeria Santini

By Santini Valeria  

Drugs, Vol. 65, Iss. 13, 2005-01 ,pp. : 1790-1791

Adis International

Access to resources Recommend Favorite

Azacitidine: A Review of its Use in the Management of Myelodysplastic Syndromes/Acute Myeloid Leukaemia

By Keating Gillian M.  

Drugs, Vol. 72, Iss. 8, 2012-05 ,pp. : 1111-1136

Adis International

Access to resources Recommend Favorite

Azacitidine beneficial in myelodysplastic syndrome

By  

Inpharma, Vol. 1, Iss. 1348, 2002-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite